Cancer Immunology, Immunotherapy

, Volume 45, Issue 6, pp 306–312

Transforming growth factor β , (TGFβ) secreted by immunogenic ex vivo human carcinoma cells, counteracts the activation and inhibits the function of autologous cytotoxic lymphocytes. Pretreatment with interferon γ and tumor necrosis factor α reduces the production of active TGFβ

  • Noémi Nagy
  • F. Vánky

DOI: 10.1007/s002620050447

Cite this article as:
Nagy, N. & Vánky, F. Cancer Immunol Immunother (1998) 45: 306. doi:10.1007/s002620050447


 We present the results obtained with an in vitro model system that resembles the in vivo tumour microenvironment, where malignant cells are in close contact with the infiltrating lymphocytes. Unmanipulated blood lymphocytes were cytotoxic against the autologous ex vivo tumour cells in 3/19 patients and this function was generated in 6-day mixed cultures in five additional cases. Production of transforming growth factor β (TGFβ) by the freshly separated tumour cells was determined in parallel. Cytotoxicity was generated by a small number of tumour cells (2–5/100 lymphocytes), while a large number (10–20/100 lymphocytes) inhibited not only the generation but also the existing lytic activity. The presence of a neutralising TGFβ-specific mAb (2G7) potentiated the activation of lymphocytes and suspended the suppression inflicted by the tumour cells. In those tumours, which expressed relatively high levels of MHC class I and ICAM-1 molecules, the quantity of secreted TGFβ interfered with the ability of tumour cells to generate cytotoxic lymphocytes. In the tumours with low expression of class I, such a correlation was not detected, indicating the primordial role of MHC class I expression in the regulation of autologous tumour recognition. Our results demonstrate the involvement of TGFβ in the impaired lymphocyte-mediated reactivity against immunogenic tumours and support a mechanism that contrasts the tolerance or anergy. Since presence of TGFβ in the microenvironment of tumours counteracts the function of cytotoxic T lymphocytes, production of this cytokine can contribute to the failure of immunotherapy.

Key words Human carcinoma Cytotoxic lymphocytes Transforming growth factor β Interferon γ Tumor necrosis factor α 

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • Noémi Nagy
    • 1
  • F. Vánky
    • 1
  1. 1.Microbiology and Tumor Biology Centre, Karolinska Institute, S-17177 Stockholm, SwedenSE
  2. 2.Research Laboratory of Radiumhemmet, Department of Oncology/Pathology, Karolinska Institute and Karolinska Hospital, S-171 76 Stockholm, SwedenSE

Personalised recommendations